PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital (CHU), Faculty of Medicine, Toulouse, France; INSERM, UMR 1027 Pharmacoepidemiology, Assessment of Drug Utilization and Drug Safety, CIC 1426 - University Paul Sabatier Toulouse, Toulouse, France. Electronic address: francois.montastruc@univ-tlse3.fr.\', \'Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital (CHU), Faculty of Medicine, Toulouse, France.\', \'Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital (CHU), Faculty of Medicine, Toulouse, France; INSERM, UMR 1027 Pharmacoepidemiology, Assessment of Drug Utilization and Drug Safety, CIC 1426 - University Paul Sabatier Toulouse, Toulouse, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1542-3565(20)31060-010.1016/j.cgh.2020.07.050
?:doi
?:hasPublicationType
?:journal
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
is ?:pmid of
?:pmid
?:pmid
  • 32721580
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all